Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

By C. Currie, J. Peters, A. Tynan, M. Evans, R. Heine, O. L. Bracco, Tony Zagar, C. Poole. The Lancet, 2010

854 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/caa1d3ffe20d49a4587dc06e93bb8528022442f2

Citations in the corpus

• Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials (2011, neutral): “level (6.4%, hazard ratio 1.52, 95% confidence interval 1.32 to 1.76) and highest 10ths (10.5%, 1.79, 1.56 to 2.06).”
• Diabetes in Older Adults (2012, neutral): “Low and high mean A1C values were associated with increased allcause mortality and cardiac events (34).”